Factors such as sample age and the method of sampling exert notable effects on PD-L1 levels [100,101,102]; in several clinical trials involving patients with advanced HCC, PD-L1 expression was retrospectively reviewed, potentially contributing to the discussed inconsistencies in the reported findings. The gene discussed is CD274; the disease is hepatocellular carcinoma.